The Best Stool Softener for Mounjaro Constipation — and What Actually Helps

It starts the same way for most people: the first few weeks on Mounjaro, the nausea grabs the headlines

The constipation creeps in quietly. Stools that were easy to pass become dry, difficult, or simply infrequent. If this sounds familiar, you are not alone, and you have not done anything wrong. The slowing of gastric emptying that makes tirzepatide so effective at reducing hunger also slows transit through the colon. Less movement through the gut means more water is absorbed from stool, and harder stools are the result.

One misconception worth setting aside gently: many people assume that because they are eating less, it is normal to go less often, and that no action is needed. That is partly true, but there is a difference between less frequency and genuinely impacted, uncomfortable stool. The latter is worth addressing directly.

The NHS patient information for tirzepatide lists constipation among the common side effects, and it confirms that gut-related effects are usually most noticeable after starting treatment or after a dose increase. Most people find things settle within a few weeks, though for some it persists throughout treatment.

Stool softeners and osmotic laxatives: the most useful tools for Mounjaro-related constipation

Stool softeners work by drawing water into stool to make it easier to pass without straining. The active ingredient docusate sodium, available in capsule form from UK pharmacies, is one of the gentlest options and is often the first choice for people whose main issue is hard, dry stool rather than infrequency. It is not a stimulant and does not cause cramping, which makes it well-tolerated alongside a medicine that already has a GI side-effect profile to manage.

Osmotic laxatives (particularly macrogol (sold under brand names such as Movicol and Laxido) and lactulose) work differently, drawing water into the bowel from surrounding tissue to soften and loosen stool. Macrogol sachets are widely regarded as effective and well-tolerated for ongoing use; they are also available without a prescription in the UK. Lactulose takes longer to act (up to 48 hours) and can cause bloating in some people, which may already be a concern if Mounjaro is causing some digestive discomfort.

Ispaghula husk (Fybogel) is a bulk-forming agent that increases stool volume and draws water in, but it requires good fluid intake to work properly. On Mounjaro, where appetite suppression can also reduce how much you drink, this is worth monitoring. Drink a full glass of water with each sachet and keep fluid intake up through the day. What to eat on treatment can also influence how well bulk-forming agents work, and our guide to the best foods on Mounjaro covers fibre-rich options that support gut health without heavy calorie loading.

Stimulant laxatives: short-term only, and with a reason

Senna and bisacodyl stimulate the muscles of the bowel wall to contract. They work faster than softeners or osmotics (often overnight) and can be genuinely useful when constipation is acute and uncomfortable. The limitation is that they are not designed for regular, ongoing use. Overuse can lead to dependence and, in some cases, electrolyte imbalance. If you find yourself reaching for senna every few days to manage ongoing Mounjaro-related constipation, that is a signal to talk to your prescriber rather than continuing on a stimulant indefinitely.

Glycerol suppositories are another short-term option that acts locally in the rectum to soften and lubricate stool. They are fast-acting (usually within 15–30 minutes) and available over the counter, but they address what is present rather than the ongoing pattern. Worth keeping available; not a management plan on their own.

The practical order of priority for most people: start with increased water and dietary fibre, add a stool softener (docusate) or macrogol sachets if needed, and use a stimulant laxative only for acute relief rather than routine management. Injection technique and timing are separate questions that come up alongside the gut side-effect conversation, choosing the right injection site does not affect constipation, but it is a common parallel query for people optimising their experience on the pen.

When to speak to a prescriber rather than managing this yourself

For most people, over-the-counter management is enough. But there are situations where the symptom needs clinical attention. Severe abdominal pain that is persistent or radiates to the back should be assessed the same day, the MHRA's Drug Safety Update guidance on GLP-1 medicines highlights acute pancreatitis as a known but infrequent side effect that requires urgent review, and it should not be confused with ordinary constipation discomfort.

If constipation is severe enough that no laxative is providing relief after 72 hours, or if you notice blood in stool, unexplained weight loss beyond what treatment would account for, or a marked change in bowel habits that does not resolve, those warrant a conversation with a GP or your prescriber. People manage a lot of discomfort quietly on treatment because they assume it is just the medicine. Sometimes it is. Sometimes it is worth checking.

Our prescribers review every repeat order and are available for aftercare seven days a week. If constipation is making treatment difficult to stick with, that is exactly the kind of thing worth raising before the next pen arrives. For a broader picture of how treatment is structured and what clinical oversight looks like, our Mounjaro overview covers the full picture. If you are still considering whether treatment is right for you, understanding where to get Mounjaro safely in the UK is a good starting point. And if cost is part of the calculation, Mounjaro pricing in the UK sets out what private treatment actually involves.

Constipation on Mounjaro is common, manageable, and not a reason to stop treatment without first exploring solutions. If eligibility has been a barrier for you previously, our page on what to do if you have been turned down for Mounjaro explains the options available. Speak to our prescribers if you would like support finding the right approach for you.